Ralph Kauten. Source: Teresa Esser.
Ralph is one of the most successful entrepreneurs in the state, in the field of bioscience, said Frank Langley, president and CEO of Point One Personal Genetic Systems.
But youll never get Ralph Kauten to admit that his success in high-tech entrepreneurship is somehow related to his own efforts.
Ive been ......Full article >>>
Kauten founded PanVera, some professors from the University of Wisconsin-Madison approached him about starting a new gene-transfer company, called Mirus Corporation.
Kauten never joined Mirus Corporation as an employee, but he served as chairman of the board and advisor. After helping the professors write their business plan, Kauten helped Mirus raise $700,0......Full article >>>
ity that is being placed in you, Kauten said. Being trustworthy means saying what you are going to do, and then finding a way to do what you said.
If people dont know you, theyre not going to invest in you.
Kauten believes that it is important for entrepreneurs to keep their investors interests in mind when making business decisions. People have entrusted you w......Full article >>>
et="blank" href=" http://www.theventurecafe.com/">The Venture Caf. She can be reached at firstname.lastname@example.org
The opinions expressed herein or statements made in the above column are solely those of the author, & do not necessarily reflect the views of Wisconsin Technology Network, LLC. (WTN). WTN, LLC accepts no legal liability or re......Full article >>>
Source:wistechnology.com By Teresa Esser 10/03/04Related biology technology :1
. TomoTherapy raises $223 million in IPO2
. Biotech officials praise focus of new venture fund3
. Investors raise $25 million for biodiesel plant4
. ZyStor seeks to raise $15M for clinical trials5
. Fusion 2007: CA chief says IT complexity raises risk6
. Fusion 2007: CEOs say bar is raised for CIOs7
. Inline intellectual property raises legal issues8
. Biotech with Madison ties raises $21M in capital9
. Third Wave Technologies to raise $14.9M through private debt10
. ConjuGon raises $3.3 million to fund clinical trials11
. Nerites raises $1 million to improve medical tech